10x Genomics (TXG) – Introduction and background |
Widgets supplied in partnership with Acuity. Pricing and sentiment does not represent ADSS data or market view.
10x Genomics is an American biotechnology company that provides gene sequencing to researchers.
Widgets supplied in partnership with Acuity. Pricing and sentiment does not represent ADSS data or market view.
10x Genomics was founded by Serge Saxonov, Ben Hindson and Kevin Ness in 2012, and provides gene sequencing to commercial and public research clients. Since the company’s 2019 IPO, major acquisitions have given the 10x Genomics business lines in epigenetic research and spatial genomics. The product mix of 10x Genomics includes Visium, that allows researchers to analyse frozen or fixed tissue samples and is also the largest overall contributor to revenue, and Chromium, which offers single cell analysis.
Enjoy highly competitive CFD pricing across global markets.
Trade CFDs globally and locally across asset classes.
Benefit from using our comprehensive and customisable trading platform.